Effect of orally administered bovine colostrum on cytokine production in vivo and in vitro in immunosuppressed mice

International Dairy Journal

Volumn 20, Issue 8, 2010, Pages 522-527

  Wan, Zhong xiao ^a   Zhang, Feng ^a   Geng, Qian ^a   Wang, Pei yu ^a   Zhou, Hong ^a   Zhang, Yu mei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4+T-LYMPHOCYTES; CYTOKINE PRODUCTION; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS; IN-VITRO; IN-VIVO; PLEIOTROPIC EFFECTS; SUPERNATANTS; T CELLS; T LYMPHOCYTES;

CELL PROLIFERATION;

CELL CULTURE;

BOVINAE; MUS;

EID: 77954864708     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2010.02.011     Document Type: Article

References (44)

1. Aalberse R.C., Schuurman J. IgG4 breaking the rules. Immunology 2002, 105:9-19.
2. Al-Ahmad R.S., Mahafzah A.M., Al-Mousa E.N. Immunological changes in acute myocardial infarction. Saudi Medical Journal 2004, 25:923-928.
3. Allison A.C. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 2000, 47:63-83.
4. Apte R.N., Voronov E. Interleukin-1 - a major pleiotropic cytokine in tumor-host interactions. Seminars in Cancer Biology 2002, 12:277-290.
5. Artym J., Zimecki M., Kruzel M.L. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Immunobiology 2003, 207:197-205.
6. Artym J., Zimecki M., Paprocka M., Kruzel M.L. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunology Letters 2003, 89:9-15.
7. Ashraf H., Mahalanabis D., Mitra A.K., Tzipori S., Fuchs G.J. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial. Acta Paediatrica 2001, 90:1373-1378.
8. Bober L.A., Grace M.J., Pugliese-Sivo C., Rojas-Triana A., Sullivan L.M., Narula S.K. The effects of colony stimulating factors on human monocyte cell function. International Journal of Immunopharmacology 1995, 17:385-392.
9. Bolke E., Orth K., Jehle P.M., Schwarz A., Steinbach G., Schleich S., et al. Enteral application of an immunoglobulin-enriched colostrum milk preparation for reducing endotoxin translocation and acute phase response in patients undergoing coronary bypass surgery - a randomized placebo-controlled pilot trial. Wiener Klinische Wochenschrift 2002, 114:923-928.
10. Boudry C., Buldgen A., Portetelle D., Collard A., Thewis A., Dehoux J.P. Effects of oral supplementation with bovine colostrum on the immune system of weaned piglets. Research in Veterinary Science 2007, 83:91-101.
11. Brode S., Cooke A. Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide. Critical Reviews in Immunology 2008, 28:109-126.
12. Carrasco F.R., Schmidt G., Romero A.L., Sartoretto J.L., Caparroz-Assef S.M., Bersani-Amado C.A., et al. Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils: evidence for humor- and cell-mediated responses. Journal of Pharmacy and Pharmacology 2009, 61:961-967.
13. Chen X.T., Li J., Wang H.L., Cheng W.M., Zhang L., Ge J.F. Immunomodulating effects of fractioned polysaccharides isolated from Yu-Ping-Feng-Powder in cyclophosphamide-treated mice. American Journal of Chinese Medicine 2006, 34:631-641.
14. Cho W.C., Leung K.N. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. Journal of Ethnopharmacology 2007, 113:132-141.
15. Dhur A., Galan P., Preziosi P., Hercberg S. Lymphocyte subpopulations in the thymus, lymph nodes and spleen of iron-deficient and rehabilitated mice. Journal of Nutrition 1991, 121:1418-1424.
16. Dray S., Mokyr M.B. Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy. Medical Oncology and Tumor Pharmacotherapy 1989, 6:77-85.
17. Floren C.H., Chinenye S., Elfstrand L., Hagman C., Ihse I. ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scandinavian Journal of Gastroenterology 2006, 41:682-686.
18. Fraiser L.H., Kanekal S., Kehrer J.P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 1991, 42:781-795.
19. Gattringer C., Huber H., Michlmayr G., Braunsteiner H. Spontaneous and conA-induced suppressor lymphocytes: a comparative study. Immunobiology 1981, 159:293-306.
20. Genoud S., Maricic I., Kumar V., Gage F.H. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 2005, 168:40-45.
21. Ginjala V., Pakkanen R. Determination of transforming growth factor-beta 1 (TGF-beta 1) and insulin-like growth factor (IGF-1) in bovine colostrum samples. Journal of Immunoassay 1998, 19:195-207.
22. Guillen C., McInnes I.B., Vaughan D.M., Kommajosyula S., Van Berkel P.H., Leung B.P., et al. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. Journal of Immunology 2002, 168:3950-3957.
23. Hagiwara K., Kataoka S., Yamanaka H., Kirisawa R., Iwai H. Detection of cytokines in bovine colostrum. Veterinary Immunology and Immunopathology 2000, 76:183-190.
24. Hori S., Takahashi T., Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Advances in Immunology 2003, 81:331-371.
25. Hoyer K.K., Dooms H., Barron L., Abbas A.K. Interleukin-2 in the development and control of inflammatory disease. Immunological Reviews 2008, 226:19-28.
26. de Jager W., Rijkers G.T. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods (San Diego, CA, USA) 2006, 38:294-303.
27. Kelly G.S. Bovine colostrums: a review of clinical uses. Alternative Medicine Review 2003, 8:378-394.
28. Klabusay L., Duda V. Side effects of cyclophosphamide during long-term therapy of progressive polyarthritis and collagenoses. Vnitrni Lekarstvi 1971, 17:446-450.
29. Lappin M.B., Campbell J.D. The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy. Blood Reviews 2000, 14:228-239.
30. Lauta V.M. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 2003, 97:2440-2452.
31. Liu H., Leung B.P. CD4+CD25+ regulatory T cells in health and disease. Clinical and Experimental Pharmacology and Physiology 2006, 33:519-524.
32. Lutsiak M.E., Semnani R.T., De Pascalis R., Kashmiri S.V., Schlom J., Sabzevari H. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 2005, 105:2862-2868.
33. Mahiou J., Walter U., Lepault F., Godeau F., Bach J.F., Chatenoud L. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice. Journal of Autoimmunity 2001, 16:431-440.
34. Manhart N., Vierlinger K., Bergmeister H., Boltz-Nitulescu G., Spittler A., Roth E. Influence of short-term protein malnutrition of mice on the phenotype and costimulatory signals of lymphocytes from spleen and Peyer's patches. Nutrition 2000, 16:197-201.
35. Nawa Y., Teshima T., Sunami K., Hiramatsu Y., Maeda Y., Yano T., et al. G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplantation 2000, 25:1035-1040.
36. Reni M., Mason W., Zaja F., Perry J., Franceschi E., Bernardi D., et al. Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial. European Journal of Cancer 2004, 40:1682-1688.
37. Rollinghoff M., Starzinski-Powitz A., Pfizenmaier K., Wagner H. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. Journal of Experimental Medicine 1977, 145:455-459.
38. Santosuosso M., Divangahi M., Zganiacz A., Xing Z. Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage-colony-stimulating factor gene transfer. Blood 2002, 99:1246-1252.
39. Shing C.M., Peake J., Suzuki K., Okutsu M., Pereira R., Stevenson L., et al. Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. Journal of Applied Physiology 2007, 102:1113-1122.
40. Szabo S.J., Sullivan B.M., Peng S.L., Glimcher L.H. Molecular mechanisms regulating Th1 immune responses. Annual Review of Immunology 2003, 21:713-758.
41. Tam S.W., Wiese R., Lee S., Gilmore J., Kumble K.D. Simultaneous analysis of eight human Th1/Th2 cytokines using microarrays. Journal of Immunological Methods 2002, 261:157-165.
42. Wei H., Xu Y., Cheng B., Xiong Y. Synergistic effects of Lactobacillus rhamnosus ZDY114 and bovine colostrums on the immunological function of mouse in vivo and in vitro. Applied Microbiology and Biotechnology 2007, 75:427-434.
43. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annual Review of Immunology 1999, 17:255-281.
44. Yoshioka Y., Kudo S., Nishimura H., Yajima T., Kishihara K., Saito K., et al. Oral administration of bovine colostrum stimulates intestinal intraepithelial lymphocytes to polarize Th1-type in mice. International Immunopharmacology 2005, 5:581-590.